Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme
The endocannabinoid system in renal cells: regulation of Na + transport by CB1 receptors through distinct cell signalling pathways
Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus
Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol
Luminal 5-HT stimulates colonic bicarbonate secretion in rats
WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo
Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus
Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats
A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier
Eicosapentaenoic acid prevents TCDD-induced oxidative stress and inflammatory response by modulating MAP kinases and redox-sensitive transcription factors
Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment
Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1
Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’, by Sandtner et al ., Br J Pharmacol 171: 1007–1018
The conservative view: is it necessary to implant a stent into the dopamine transporter?
Interleukin-18 as a target for modulation of irinotecan-induced intestinal toxicity: a step towards a better therapeutic index?: Commentary on Lima-Junior et al ., Br J Pharmacol 171: 2335–2350
PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al ., Br J Pharmacol 171: 1521–1533